Also for lung adenocarcinomas, a tumour type similar to ITAC, most studies report a worse survival in PD-L1-positive cases [29,30], which may be explained by PD-L1 immunosuppressive effect, which prevents cytolysis by activated CD8+ TILs. The gene discussed is CD8A; the disease is lung adenocarcinoma.